{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-000110","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.169269+00:00","generated_at":"2026-05-16T11:12:01.897944+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"KALA BIO enters $15M at-market offering agreement with H.C. Wainwright","bullets":["Aggregate market value of shares eligible for sale under ATM prospectus supplement currently $15,000,000.","Sales commission to H.C. Wainwright set at 3.0% of gross sales price.","Company has no obligation to sell any shares under the agreement; either party may suspend offerings.","Subject to terms, Wainwright may sell shares on Nasdaq or in privately negotiated transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-000110","json":"https://secwatch.observer/filing/0001829126-26-000110.json","markdown":"https://secwatch.observer/filing/0001829126-26-000110.md","text":"https://secwatch.observer/filing/0001829126-26-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/0001829126-26-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000182912626000110/kalabio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:12:01.897944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}